健康元(600380.SH)：莱康奇塔单抗注射液上市许可申请获受理

Core Viewpoint - The company Health元 (600380.SH) announced that its subsidiary Zhuhai Lizhu Antibody Biotechnology Co., Ltd. has received the acceptance notice from the National Medical Products Administration for the domestic production registration application of "Lai Kang Qi Ta Antibody Injection" [1] Group 1 - The acceptance number for the registration application is CXSS2500144 [1]